SEC Filing Details
Document Details
Form
Filing Date
Jun 18, 2026
Document Date
May 18, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Lyell Immunopharma, Inc.
Issuer
LYELL IMMUNOPHARMA, INC.
Filer
INNOVATIVE CELLULAR THERAPEUTICS HOLDINGS LTD